Who
INVESTOR AB
10% owner
Company insider
Files Form 4 as: 10% owner, Nasdaq; 10% owner, Agile Therapeutics; 10% owner, Greenway Medical Technologies; Other, Tangoe; 10% owner, Achillion Pharmaceuticals; 10% owner, Ista Pharmaceuticals.
In numbers
- Trades disclosed
- 82
- Buys
- 9
- Sells
- 24
- Bought
- $63.7M
- Sold
- $4.9M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 9 Feb 2007
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | NDAQ NasdaqExchanges & fin. data | SEC FORM 4 Bought | $4.9M56,782 at $85.98 | filing |
| 11 Jun 2026filed 15 Jun 2026 | NDAQ NasdaqExchanges & fin. data | SEC FORM 4 Bought | $4.9M56,782 at $85.98 | filing |
| 13 Feb 2026filed 13 Feb 2026 | NDAQ NasdaqExchanges & fin. data | SEC FORM 4 Bought | $15.8M200,000 at $79.18 | filing |
| 13 Feb 2026filed 13 Feb 2026 | NDAQ NasdaqExchanges & fin. data | SEC FORM 4 Bought | $15.8M200,000 at $79.18 | filing |
| 29 May 2014filed 29 May 2014 | Agile Therapeutics | SEC FORM 4 Bought | $15.1M2,509,949 at $6.00 | filing |
| 22 May 2014filed 27 May 2014 | Agile Therapeutics | SEC FORM 4 Bought | $6.0M1,000,000 at $6.00 | filing |
| 1 Nov 2013filed 5 Nov 2013 | Greenway Medical Technologies | SEC FORM 4 Code U | $100.2M4,922,009 at $20.35 | filing |
| 1 Nov 2013filed 5 Nov 2013 | Greenway Medical Technologies | SEC FORM 4 Code U | $42.9M2,109,431 at $20.35 | filing |
| 21 May 2012filed 23 May 2012 | NDAQ NasdaqExchanges & fin. data | SEC FORM 4 Bought | $876K40,000 at $21.90 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologiesoption or derivative | SEC FORM 4 Code C | —1,750,000 at $0.00 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologiesoption or derivative | SEC FORM 4 Code C | —750,000 at $0.00 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologiesoption or derivative | SEC FORM 4 Code C | —768,637 at $0.00 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologiesoption or derivative | SEC FORM 4 Code C | —329,416 at $0.00 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologies | SEC FORM 4 Code C | —2,735,526 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologies | SEC FORM 4 Code C | —951,188 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologies | SEC FORM 4 Code C | —1,172,368 | filing |
| 7 Feb 2012filed 9 Feb 2012 | Greenway Medical Technologies | SEC FORM 4 Code C | —407,652 | filing |
| 1 Aug 2011filed 2 Aug 2011 | Tangoe | SEC FORM 4 Sold | $1.2M132,361 at $9.30 | filing |
| 31 Dec 2009filed 5 Jan 2010 | Achillion Pharmaceuticals | SEC FORM 4 Sold | $180K56,000 at $3.21 | filing |
| 31 Dec 2009filed 5 Jan 2010 | Achillion Pharmaceuticals | SEC FORM 4 Sold | $126K39,200 at $3.21 | filing |
News
Head-To-Head Comparison: Nasdaq (NASDAQ:NDAQ) vs. Procap Financial (NASDAQ:BRR)NDAQ · tickerreport.com · 16 Oct 2026Nasdaq (NASDAQ:NDAQ) EVP Sells $105,896.25 in StockNDAQ · dailypolitical.com · 14 Oct 2026Nasdaq (NASDAQ:NDAQ) Stock: Insider Jeremy Skule Sells 1,125 SharesNDAQ · tickerreport.com · 14 Oct 2026
0 headlines in the last 90 days name INVESTOR AB; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.